Impaired T cell death and lupus-like autoimmunity in T cell-specific adapter protein-deficient mice

Journal of Experimental Medicine

Volumn 198, Issue 5, 2003, Pages 809-821

  Drappa, Jorn ^a   Kamen, Lynn A ^a,b   Chan, Elena ^a   Georgiev, Maria ^a   Ashany, Dalit ^a   Marti, Francesc ^a,b   King, Philip D ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Autoimmunity; Glomerulonephritis; Signal transduction; T lymphocyte

Indexed keywords

ADAPTOR PROTEIN; AUTOANTIBODY;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL DEATH; CELL PROLIFERATION; CELL SPECIFICITY; COMPLEX FORMATION; GENE TARGETING; GLOMERULONEPHRITIS; HYPERGAMMAGLOBULINEMIA; LUPUS ERYTHEMATOSUS; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TARGET CELL;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; AUTOIMMUNE DISEASES; CARRIER PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; DISEASE MODELS, ANIMAL; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-2; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0042886906     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.20021358     Document Type: Article

References (44)

1. Spurkland, A., J.E. Brinchmann, G. Markussen, F. Pedeutour, E. Munthe, T. Lea, F. Vartdal, and H.C. Aasheim. 1998. Molecular cloning of a T cell-specific adapter protein (TSAd) containing an Src homology (SH) 2 domain and putative SH3 and phosphotyrosine binding sites. J. Biol. Chem. 273:4539-4546.
2. Choi, Y.B., C.K. Kim, and Y. Yun. 1999. Lad, an adapter protein interacting with the SH2 domain of p561ck, is required for T cell activation. J. Immunol. 163:5242-5249.
3. Rajagopal, K., C.L. Sommers, D.C. Decker, E.O. Mitchell, U. Korthauer, A.I. Sperling, C.A. Kozak, P.E. Love, and J.A. Bluestone. 1999. RIBP, a novel Rlk/Txk- and itk-binding adaptor protein that regulates T cell activation. J. Exp. Med. 190:1657-1668.
4. Sun, W., K. Kesavan, B.C. Schaefer, T.P. Garrington, M. Ware, N.L. Johnson, E.W. Gelfand, and G.L. Johnson. 2001. MEKK2 associates with the adapter protein Lad/RIBP and regulates the MEK5-BMK1/ERK5 pathway. J. Biol. Chem. 276:5093-5100.
5. Marti, F., N.H. Post, E. Chan, and P.D. King. 2001. A transcription function for the T cell-specific adapter (TSAd) protein in T cells: critical role of the TSAd Src homology 2 domain. J. Exp. Med. 193:1425-1430.
6. Bullard, D.C., P.D. King, M.J. Hicks, B. Dupont, A.L. Beaudet, and K.B. Elkon. 1997. Intercellular adhesion molecule-1 deficiency protects MRL/MpJ-Fas(lpr) mice from early lethality. J. Immunol. 159:2058-2067.
7. Theofilopoulos, A.N., and F.J. Dixon. 1985. Murine models of systemic lupus erythematosus. Adv. Immunol. 37:269-390.
8. Cohen, P.L., and R.A. Eisenberg. 1991. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9:243-269.
9. Tan, E.M., E.K. Chan, K.F. Sullivan, and R.L. Rubin. 1988. Antinuclear antibodies (ANAs): diagnostically specific immune markers and clues toward the understanding of systemic autoimmunity. Clin. Immunol. Immunopathol. 47:121-141.
10. Dubois, E.L. 1975. Serologic abnormalities in spontaneous and drug-induced systemic lupus erythematosus. J. Rheumatol. 2:204-214.
11. Gershwin, M.E., and A.D. Steinberg. 1974. Qualitative characteristics of anti-DNA antibodies in lupus nephritis. Arthritis Rheum. 17:947-954.
12. Harris, E.N., A.E. Gharavi, M.L. Boey, B.M. Patel, C.G. Mackworth-Young, S. Loizou, and G.R. Hughes. 1983. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet. 2:1211-1214.
13. Satoh, M., and W.H. Reeves. 1994. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J. Exp. Med. 180:2341-2346.
14. Satoh, M., A. Kumar, Y.S. Kanwar, and W.H. Reeves. 1995. Anti-nuclear antibody production and immune-complex glomerulonephritis in BALB/c mice treated with pristane. Proc. Natl. Acad. Sci. USA. 92:10934-10938.
15. Richards, H.B., M. Satoh, M. Shaw, C. Libert, V. Poli, and W.H. Reeves. 1998. Interleukin 6 dependence of anti-DNA antibody production: evidence for two pathways of autoantibody formation in pristane-induced lupus. J. Exp. Med. 188: 985-990.
16. Satoh, M., H.B. Richards, V.M. Shaheen, H. Yoshida, M. Shaw, J.O. Naim, P.H. Wooley, and W.H. Reeves. 2000. Widespread susceptibility among inbred mouse strains to the induction of lupus autoantibodies by pristane. Clin. Exp. Immunol. 121:399-405.
17. Satoh, M., J.P. Weintraub, H. Yoshida, V.M. Shaheen, H.B. Richards, M. Shaw, and W.H. Reeves. 2000. Fas and Fas ligand mutations inhibit autoantibody production in pristane-induced lupus. J. Immunol. 165:1036-1043.
18. Kawabe, Y., and A. Ochi. 1991. Programmed cell death and extrathymic reduction of Vbeta8+ CD4+ T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature. 349:245-248.
19. Brunner, T., R.J. Mogil, D. LaFace, N.J. Yoo, A. Mahboubi, F. Echeverri, S.J. Martin, W.R. Force, and D.H. Lynch. 1995. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas. Nature. 373:441-444.
20. Dhein, J., H. Walczak, C. Baumler, K.M. Debatin, and P.H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature. 373:438-441.
21. Ju, S.T., D.J. Panka, H. Cui, R. Ettinger, M. el-Khatib, D.H. Sherr, B.Z. Stanger, and A. Marshak-Rothstein. 1995. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature. 373:444-448.
22. Hildeman, D.A., Y. Zhu, T.C. Mitchell, P. Bouillet, A. Strasser, J. Kappler, and P. Marrack. 2002. Activated T cell death in vivo mediated by proapoptotic bcl-2 family member bim. Immunity. 16:759-767.
23. Hildeman, D.A., Y. Zhu, T.C. Mitchell, J. Kappler, and P. Marrack. 2002. Molecular mechanisms of activated T cell death in vivo. Curr. Opin. Immunol. 14:354-359.
24. Rathmell, J.C., and C.B. Thompson. 2002. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell. 109:S97-S107.
25. Breckenridge, D.G., M. Nguyen, S. Kuppig, M. Peth, and G.C. Shore. 2002. The procaspase-8 isoform, procaspase-8L, recruited to the BAP31 complex at the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA. 99:4331-4336.
26. Fernandez-Salas, E., K.S. Suh, V.V. Speransky, W.L. Bowers, J.M. Levy, T. Adams, K.R. Pathak, L.E. Edwards, D.D. Hayes, C. Cheng, et al. 2002. mtCLIC/CLIC4, an organellular chloride channel protein, is increased by DNA damage and participates in the apoptotic response to p53. Mol. Cell. Biol. 22:3610-3620.
27. Juin, P., A.O. Hueber, T. Littlewood, and G. Eran. 1999. c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release. Genes Dev. 13:1367-1381.
28. Xanthoudakis, S., S. Roy, D. Rasper, T. Hennessey, Y. Aubin, R. Cassady, P. Tawa, R. Ruel, A. Rosen, and D.W. Nicholson. 1999. Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J. 18:2049-2056.
29. Refaeli, Y., L. Van Parijs, S.I. Alexander, and A.K. Abbas. 2002. Interferon γ is required for activation-induced death of T lymphocytes. J. Exp. Med. 196:999-1005.
30. Sadlack, B., H. Merz, H. Schorle, A. Schimpl, A.C. Feller, and I. Horak. 1993. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell. 75:253-261.
31. Sadlack, B., J. Lohler, H. Schorle, G. Klebb, H. Haber, E. Sickel, R.J. Noelle, and I. Horak. 1995. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur. J. Immunol. 25:3053-3059.
32. Suzuki, H., T.M. Kundig, C. Furlonger, A. Wakeham, E. Timms, T. Matsuyama, R. Schmits, J.J. Simard, P.S. Ohashi, and H. Griesser. 1995. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. Science. 268:1472-1476.
33. Willerford, D.M., J. Chen, J.A. Ferry, L. Davidson, A. Ma, and F.W. Alt. 1995. Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity. 3:521-530.
34. Li, X.C., G. Demirci, S. Ferrari-Lacraz, C. Groves, A. Coyle, T.R. Malek, and T.B. Strom. 2001. IL-15 and IL-2: a matter of life and death for T cells in vivo. Nat. Med. 7:114-118.
35. Bachmaier, K., C. Krawczyk, I. Kozieradzki., Y.Y. Kong, T. Sasaki, A. Oliveira-dos-Santos, S. Mariathasan, D. Bouchard, A. Wakeham, A. Itie, et al. 2000. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cb1-b. Nature. 403:211-216.
36. Sun, H., B. Lu, R.Q. Li, R.A. Flavell, and R. Taneja. 2001. Defective T cell activation and autoimmune disorder in Stra13-deficient mice. Nat. Immunol. 2:1040-1047.
37. Bouillet, P., D. Metcalf, D.C. Huang, D.M. Tarlinton, T.W. Kay, F. Kontgen, J.M. Adams, and A. Strasser. 1999. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 286:1735-1738.
38. Majeti, R., Z. Xu, T.G. Parslow, J.L. Olson, D.I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell. 103:1059-1070.
39. Strasser, A., S. Whittingham, D.L. Vaux, M.L. Bath, J.M. Adams, S. Cory, and A.W. Harris. 1991. Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA. 88:8661-8665.
40. Kelley, V.E., and J.B. Roths. 1985. Interaction of mutant lpr gene with background strain influences renal disease. Clin. Immunol. Immunopathol. 37:220-229.
41. Izui, S., V.E. Kelley, K. Masuda, H. Yoshida, J.B. Roths, and E.D. Murphy. 1984. Induction of various autoantibodies by mutant gene lpr in several strains of mice. J. Immunol. 133: 227-233.
42. Van Parijs, L., D.A. Peterson, and A.K. Abbas. 1998. The Fas/Fas ligand pathway and Bcl-2 regulate T cell responses to model self and foreign antigens. Immunity. 8:265-274.
43. Ohashi, P.S. 2002. T-cell signalling and autoimmunity: molecular mechanisms of disease. Nat. Rev. Immunol. 2:427-438.
44. Dai, K.Z., H.F. Harbo, E.G. Celius, A. Oturai, P.S. Sorensen, L.P. Ryder, P. Datta, A. Svejgaard, J. Hillert, S. Fredrikson, et al. 2001. The T cell regulator gene SH2D2A contributes to the genetic susceptibility of multiple sclerosis. Genes Immun. 2:263-268.